Abstract
The human T-lymphotropic virus type I (HTLV-I) is a retrovirus associated with a chronic myelopathy known as HTLV-I-Associated Myelopathy or Tropical Spastic Paraparesis (HAM/TSP). The main objective was to assess the frequency of erectile dysfunction (ED) in HTLV-I-infected individuals from Salvador and other cities from Bahia, Brazil, as well as to verify if sexual dysfunction correlates with urinary symptoms and overall neurological impairment. From January 2001 to April 2004, 218 HTLV-I carriers (111 male and 107 female subjects) had complete clinical, neurological, and urological evaluation. They were assessed using standardized questionnaires to determine urinary complaints (Urinary Distress Inventory) and ED (Brief Male Sexual Function Inventory). Neurological impairment was established by Expanded Disability Status Scale (EDSS) from 0 to 10. HAM/TSP was considered as EDSS≥2. A total of 17 males had clinically defined HAM/TSP (group 1). From the 94 HTLV-I-infected males, 62 were selected (group 2) and paired by age with patients in group 1. A total of 79 individuals were selected for this study. The age ranged from 35 to 81 y (mean=47.9±9.65). The percentage of ED in the studied population was 40.5%. In the HAM/TSP group, ED frequency was 88.2%. The associations among sexual dissatisfaction, erectile dysfunction, urinary symptoms (frequency, nocturia, and urgency) and EDSS≥2 were statistically significant. In HAM/TSP, there is a slow and progressive degeneration of the lateral funiculus of the spinal cord. HTLV-I-infected individuals present a high frequency of ED and it is closely associated to urinary symptoms and the overall neurological picture. The HTLV-I carriers already had prominent compromise of the sexual activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gessain A et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410.
Osame M et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031–1032.
Bangham CR . HTLV-1 infections. J Clin Pathol 2000; 53: 581–586.
Araujo Ade Q et al. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil. Acta Neurol Scand 1993; 88: 59–62.
Araujo Ade Q et al. HTLV-I infection and neurological disease in Rio de Janeiro. J Neurol Neurosurg Psychiatry 1992; 55: 153–155.
Leads from the MMWR. Licensure of screening tests for antibody to human T-lymphotropic virus type I. JAMA 1989; 261: 513, 518–520, 525.
Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
de Boer BJ et al. Erectile dysfunction in primary care: prevalence and patient characteristics. The ENIGMA study. Int J Impot Res 2004; 16: 358–364.
Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.
Harvey MA, Kristjansson B, Griffith D, Versi E . The Incontinence Impact Questionnaire and the Urogenital Distress Inventory: a revisit of their validity in women without a urodynamic diagnosis. Am J Obstet Gynecol 2001; 185: 25–31.
O'Leary MP et al. A brief male sexual function inventory for urology. Urology 1995; 46: 697–706.
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.
DasGupta R, Fowler CJ . Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs 2003; 63: 153–166.
Zorzon M et al. Sexual dysfunction in multiple sclerosis: a case–control study. I. Frequency and comparison of groups. Mult Scler 1999; 5: 418–427.
Betts CD, Jones SJ, Fowler CG, Fowler CJ . Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition. Brain 1994; 117: 1303–1310.
Mazza O, Zeller F . Tratamiento farmacológico de la disfunción eréctil. Editorial Panamericana: Buenos Aires, 1997.
Aye MM et al. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol (Berl) 2000; 100: 245–252.
Kasahata N et al. Acute human T-lymphotropic virus type 1-associated myelopathy: a clinicopathologic study. Arch Neurol 2003; 60: 873–876.
Castro-Costa CM et al. Neuropathology of two Brazilian autopsied cases of tropical spastic paraparesis/HTLV-I associated myelopathy (TSP/HAM) of long evolution. Arq Neuropsiquiatr 2002; 60: 531–536.
Acknowledgements
We are indebted to Dr Sidney Glina for reviewing the manuscript, advice and encouragement; Dr Valdir Lisboa from STS for referring eligible patients to our study. We also thank other members of the HTLV-I Multidisciplinary Outpatient Clinic for collaboration during the study: Dr Maria Aurélia Porto and Dr Adelmir Machado. This work was supported by the Brazilian National Research Council (CNPq) and Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB). Edgar M Carvalho is a senior investigator of CNPq.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Castro, N., Oliveira, P., Freitas, D. et al. Erectile dysfunction and HTLV-I infection: a silent problem. Int J Impot Res 17, 364–369 (2005). https://doi.org/10.1038/sj.ijir.3901335
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901335